Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

At Trump’s GOP convention, there’s little to be heard on health care

No talk of Obamacare. Or abortion.

19 Jul 2024

Does hormone-modulating therapy for breast cancer treatment affect risk for Alzheimer disease and related dementias?

The association between hormone-modulating therapy (HMT) for breast cancer treatment and the risk of developing Alzheimer's disease and related dementias.

19 Jul 2024

Study examines brain activity and time perception over minutes and hours

Ever hear the old adage that time flies when you're having fun? A new study by a team of UNLV researchers suggests that there's a lot of truth to the trope.

19 Jul 2024

New study links cellular health to well-being of dementia caregivers

It's no secret that the caregivers of spouses with memory impairment face enormous amounts of stress.

18 Jul 2024

Novel insights into how exercise functions as an antidepressant

Researchers from University College London propose a novel framework linking reduced inflammation and boosted dopamine transmission through exercise to alleviate depressive symptoms.

18 Jul 2024

Increased exposure to residential greenery may help stave off cognitive decline

A new study found that increased exposure to residential greenery may help stave off cognitive decline by an annual rate of eight months.

17 Jul 2024

Breakthrough interactive atlas offers pathway to precision medicine for TBI patients

Researchers at Phoenix's Barrow Neurological Institute and the University of Pittsburgh have created a vast interactive atlas that may eventually help doctors use precision medicine to target treatments for traumatic brain injury (TBI) patients – and could replace the existing uniform treatment model.

16 Jul 2024

Predicting Alzheimer's decline: New model offers personalized insights for patients

Researchers developed a model to predict cognitive decline in Alzheimer's patients using clinical and biomarker data, improving personalized treatment plans.

16 Jul 2024

New study aims to examine how sleep patterns affect neurocognition in older women

Alzheimer's disease, the most common type of dementia, currently affects twice as many women as men, with minority populations predicted to witness the most significant increase in cases in the coming years, according to the Centers for Disease Control and Prevention.

16 Jul 2024

Hormone modulating therapy may lower dementia risk in breast cancer survivors

Hormone modulating therapy (HMT) used for the treatment of breast cancer was associated with a 7% lower risk of developing Alzheimer's disease and related dementias later in life, according to a new study published today in JAMA Network Open.

16 Jul 2024

Combined impact of social isolation and loneliness found to diminish cognitive health

The individual and combined effects of social isolation (SI) and loneliness (LON) on memory in middle-aged and older adults over six years.

15 Jul 2024

Review highlights unique characteristics and mechanisms of ferroptosis

Junxia Min, Fudi Wang, et al., at Zhejiang University School of Medicine, China, provided an in-depth review on the programmed cell death known as ferroptosis, which is driven by iron-dependent lipid peroxidation.

14 Jul 2024

Study reveals how inflammation weakens muscles during illness

Infections and neurodegenerative diseases cause inflammation in the brain. But for unknown reasons, patients with brain inflammation often develop muscle problems that seem to be independent of the central nervous system. Now, researchers at Washington University School of Medicine in St. Louis have revealed how brain inflammation releases a specific protein that travels from the brain to the muscles and causes a loss of muscle function.

13 Jul 2024

Study reveals potential cognitive benefits of antidiabetic drugs

Investigators analyzing the potential cognitive effects of antidiabetic medications in records of more than 1.5 million patients with type 2 diabetes mellitus (T2DM) found risks of dementia and Alzheimer's disease (AD) were significantly lower in patients treated with metformin and sodium glucose co-transporter-2 inhibitors (SGLT-2i) compared to other antidiabetic drugs.

12 Jul 2024

Alzheimer's Disease News and Research

Further Reading

At Trump’s GOP convention, there’s little to be heard on health care

Does hormone-modulating therapy for breast cancer treatment affect risk for Alzheimer disease and related dementias?

Study examines brain activity and time perception over minutes and hours

New study links cellular health to well-being of dementia caregivers

Novel insights into how exercise functions as an antidepressant

Increased exposure to residential greenery may help stave off cognitive decline

Breakthrough interactive atlas offers pathway to precision medicine for TBI patients

Predicting Alzheimer's decline: New model offers personalized insights for patients

New study aims to examine how sleep patterns affect neurocognition in older women

Hormone modulating therapy may lower dementia risk in breast cancer survivors

Combined impact of social isolation and loneliness found to diminish cognitive health

Review highlights unique characteristics and mechanisms of ferroptosis

Study reveals how inflammation weakens muscles during illness

Study reveals potential cognitive benefits of antidiabetic drugs

Scientists map molecules within human brain for first time

Antibody fragment discovery could lead to much-needed treatment for light chain amyloidosis

Experts identify sex and gender differences in cognitive resistance and resilience to Alzheimer's disease

Animal model sheds light on the role understudied brain organ in repairing stroke damage

Case Western Reserve University receives $1.5M grant for oral drug trial to prevent blindness in RP patients

AI model revolutionizes dementia diagnosis with high accuracy across multiple data sources

eBook: Hallmarks of Neurodegeneration eBook

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Latest News